At a glance
- Originator NovaDel Pharma
- Class Antiallergics; Dibenzocycloheptenes; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Seasonal allergic rhinitis
Most Recent Events
- 15 Nov 2004 Suspended - Phase-II for Seasonal allergic rhinitis in USA (Transmucosal)
- 15 Nov 2004 NovaDel Pharma has completed a Phase-II trial in Seasonal allergic rhinitis in the USA
- 18 Feb 2003 Phase-II clinical trials in Seasonal allergic rhinitis in USA (Transmucosal)